132 related articles for article (PubMed ID: 22878573)
1. [Pharmacological and clinical profile of gabapentin enacarbil: a novel drug for the treatment of restless legs syndrome].
Kakimoto S; Ozawa T; Igarashi K; Tokuno T; Kaku S; Seki N
Nihon Yakurigaku Zasshi; 2012 Aug; 140(2):85-92. PubMed ID: 22878573
[No Abstract] [Full Text] [Related]
2. Gabapentin enacarbil in restless legs syndrome.
Merlino G; Serafini A; Lorenzut S; Sommaro M; Gigli GL; Valente M
Drugs Today (Barc); 2010 Jan; 46(1):3-11. PubMed ID: 20200691
[TBL] [Abstract][Full Text] [Related]
3. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome.
Merlino G; Serafini A; Young JJ; Robiony F; Gigli GL; Valente M
Curr Opin Investig Drugs; 2009 Jan; 10(1):91-102. PubMed ID: 19127491
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin enacarbil for the treatment of restless legs syndrome (RLS).
Burke RA; Faulkner MA
Expert Opin Pharmacother; 2011 Dec; 12(18):2905-14. PubMed ID: 22077768
[TBL] [Abstract][Full Text] [Related]
5. Gabapentin enacarbil for treatment of restless legs syndrome in adults.
Hayes WJ; Lemon MD; Farver DK
Ann Pharmacother; 2012 Feb; 46(2):229-39. PubMed ID: 22298601
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin enacarbil: in patients with restless legs syndrome.
Scott LJ
CNS Drugs; 2012 Dec; 26(12):1073-83. PubMed ID: 23179641
[TBL] [Abstract][Full Text] [Related]
7. Gabapentin Enacarbil: A Review in Restless Legs Syndrome.
Kim ES; Deeks ED
Drugs; 2016 May; 76(8):879-87. PubMed ID: 27146056
[TBL] [Abstract][Full Text] [Related]
8. Gabapentin enacarbil (XP13512/GSK1838262) as an alternative treatment to dopaminergic agents for restless legs syndrome.
Imamura S; Kushida C
Expert Opin Pharmacother; 2010 Aug; 11(11):1925-32. PubMed ID: 20629607
[TBL] [Abstract][Full Text] [Related]
9. A 52-week study of gabapentin enacarbil in restless legs syndrome.
Ellenbogen AL; Thein SG; Winslow DH; Becker PM; Tolson JM; Lassauzet ML; Chen D
Clin Neuropharmacol; 2011; 34(1):8-16. PubMed ID: 21242741
[TBL] [Abstract][Full Text] [Related]
10. Gabapentin encarbil (Horizant) for restless leg syndrome.
Med Lett Drugs Ther; 2011 Sep; 53(1372):70-1. PubMed ID: 21897349
[TBL] [Abstract][Full Text] [Related]
11. Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.
VanMeter SA; Kavanagh ST; Warren S; Barrett RW
CNS Drugs; 2012 Sep; 26(9):773-80. PubMed ID: 22849331
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics and pharmacodynamics of gabapentin after administration of gabapentin enacarbil.
Lal R; Sukbuntherng J; Luo W; Tovera J; Lassauzet ML; Cundy KC
J Clin Pharmacol; 2013 Jan; 53(1):29-40. PubMed ID: 23400741
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
Walters AS; Ondo WG; Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Clin Neuropharmacol; 2009; 32(6):311-20. PubMed ID: 19667976
[TBL] [Abstract][Full Text] [Related]
14. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
[TBL] [Abstract][Full Text] [Related]
15. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.
Bogan RK; Bornemann MA; Kushida CA; Trân PV; Barrett RW;
Mayo Clin Proc; 2010 Jun; 85(6):512-21. PubMed ID: 20511481
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.
Lal R; Ellenbogen A; Chen D; Zomorodi K; Atluri H; Luo W; Tovera J; Hurt J; Bonzo D; Lassauzet ML; Vu A; Cundy KC
Clin Neuropharmacol; 2012; 35(4):165-73. PubMed ID: 22664749
[TBL] [Abstract][Full Text] [Related]
17. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.
Winkelman JW; Bogan RK; Schmidt MH; Hudson JD; DeRossett SE; Hill-Zabala CE
Mov Disord; 2011 Sep; 26(11):2065-72. PubMed ID: 21611981
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.
Lee DO; Ziman RB; Perkins AT; Poceta JS; Walters AS; Barrett RW;
J Clin Sleep Med; 2011 Jun; 7(3):282-92. PubMed ID: 21677899
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome.
Avidan AY; Lee D; Park M; Jaros MJ; Shang G; Kim R
CNS Drugs; 2016 Apr; 30(4):305-16. PubMed ID: 27067343
[TBL] [Abstract][Full Text] [Related]
20. Predictors of clinical response in a double-blind placebo controlled crossover trial of gabapentin enacarbil for restless legs syndrome.
Winkelman JW; Jaros MJ
Sleep Med; 2018 Aug; 48():1-7. PubMed ID: 29807228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
